New Delhi, May 29
The Singapore Supreme Court has dismissed an appeal by erstwhile Ranbaxy Laboratories’ former promoters Malvinder Singh and Shivinder Singh against a high court order that declined to set aside an arbitration award in favour of Japan’s Daichii Sankyo.
Confirming the development, Anand Pathak, Managing Partner P&A Law Offices, representing Japanese pharma firm Daaichi Sankyo said, “The Singapore Supreme Court has dismissed the appeal.” He further said, "We have been trying to enforce the award and we will continue in a very focused way to enforce the award, now that there is a finality to the appeal." With interests and everything, the total amount is in excess of Rs 3,500 crore, Pathak said. — PTI
Join Whatsapp Channel of The Tribune for latest updates.
4
5